Tag: Investing in Hollister
Hollister Biosciences Inc. Announces Filing of Amended and Restated Interim Financial Statements and MD&A for the Three and Nine Months Ended September 30, 2020
Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it’s 100% owned subsidiary is a category leader with over 4 million grams sold throughout the state in 2020
Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $2.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019
Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line
Allied Corp. and Hollister Biosciences Have Now Delivered TACTICAL RELIEF™ Products into Distribution
Hollister Biosciences Inc. Wholly Owned subsidiary Hollister Cannabis Co Receives Trademark Approval for Brand HashBone
Hollister Biosciences Inc. Launches Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery
